Vanguard-Group

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-09
Total Holdings
16,744
Total Value
5531119721493
Accession Number
0001752724-25-099331
Form Type
13F-HR
Manager Name
Vanguard-Group
Data Enrichment
97% identified
16,290 identified454 unidentified

Holdings

16,744 positions • $5.5T total value
Manager:
Search and click to pin securities to the top
Page 158 of 214
C4 Therapeutics, Inc.
Shares:3.4M
Value:$5.4M
% of Portfolio:0.0% ($5.4M/$5.5T)
RIVERVIEW BANCORP INC
Shares:952.4K
Value:$5.4M
% of Portfolio:0.0% ($5.4M/$5.5T)
Shares:2.4M
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
TAYLOR DEVICES, INC.
Shares:165.6K
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
Neumora Therapeutics, Inc.
Shares:5.3M
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
Traeger, Inc.
Shares:3.2M
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
Tango Therapeutics, Inc.
Shares:3.9M
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
GEOSPACE TECHNOLOGIES CORP
Shares:736.1K
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
Upland Software, Inc.
Shares:1.9M
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
LIGHTBRIDGE Corp
Shares:705.9K
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
CHEGG, INC
Shares:8.2M
Value:$5.3M
% of Portfolio:0.0% ($5.3M/$5.5T)
scPharmaceuticals Inc.
Shares:2.0M
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
Lyell Immunopharma, Inc.
Shares:9.7M
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
832248207
Shares:256.3K
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
INTEST CORP
Shares:746.4K
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
Atomera Inc
Shares:1.3M
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
Zentalis Pharmaceuticals, Inc.
Shares:3.3M
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
TEEKAY CORP LTD
Shares:786.3K
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
Reservoir Media, Inc.
Shares:675.6K
Value:$5.2M
% of Portfolio:0.0% ($5.2M/$5.5T)
KEWAUNEE SCIENTIFIC CORP /DE/
Shares:130.2K
Value:$5.1M
% of Portfolio:0.0% ($5.1M/$5.5T)